IVF · Registration Statement (Form S-1) · Filed February 2, 2026

Invo Fertility Inc — S-1 exhibit

ex107.htm

Exhibit 107

Calculation of Registration Fee

Form S-1

(Form Type)

INVO Fertility, Inc.

	Security type	Title of securities to be registered	Fee calculation rule	Amount to be registered		Proposed maximum offering price per share (1)		Proposed maximum aggregate offering price (1)		Fee rate		Amount of registration fee
Fees to be paid	Equity	Shares of Common Stock, $0.0001 par value underlying the Common Warrants	Other		9,467,456	$	1.59	$	15,053,255.04		0.00013810	$	2,078.85
		Total offering amounts			9,467,456			$	15,053,255.04			$	2,078.85
		Total fees previously paid											-
		Total fee offsets											-
		Net fees dues										$	2,078.85

(1)

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based upon the average of the high and low sale price of the Registrant’s common stock on December 16, 2025 as reported in the Nasdaq Stock Market.

N/A

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer